Long-term memory depends on the control of activity-dependent neuronal gene expression, which is regulated by epigenetic modifications. The epigenetic modification of histones is orchestrated by the opposing activities of two classes of regulatory complexes: permissive co-activators and silencing co-repressors. Much work has focused on co-activator complexes, but little is known about the co-repressor complexes that suppress the expression of plasticity-related genes. Here, we define a critical role for the co-repressor SIN3A in memory and synaptic plasticity, showing that postnatal neuronal deletion of Sin3a enhances hippocampal long-term potentiation and long-term contextual fear memory. SIN3A regulates the expression of genes encoding proteins in the post-synaptic density. Loss of SIN3A increases expression of the synaptic scaffold Homer1, alters the mGluR1α-and mGluR5-dependence of long-term potentiation, and increases activation of extracellular signal regulated kinase (ERK) in the hippocampus after learning. Our studies define a critical role for co-repressors in modulating neural plasticity and memory consolidation and reveal that Homer1/mGluR signaling pathways may be central molecular mechanisms for memory enhancement.
INTRODUCTION
Long-term memory consolidation and hippocampal long-term potentiation depend on activity-dependent neuronal gene expression, which is in turn regulated by epigenetic mechanisms such as post-translational histone modifications (1, 2) . Histone acetylation is associated with transcriptional activation, and both histone acetylation and expression of acetylation-regulated genes are increased during memory consolidation (1, (3) (4) (5) .
Acetylation levels are determined by the activity of histone acetyltransferase (HAT) and histone deacetylase (HDAC) enzymes, which are recruited to chromatin by association with co-activator and co-repressor proteins (6) (7) (8) . For example, HATs such as CBP and p300 are recruited by the transcription factor and co-activator protein CREB in response to signaling cascades triggered by synaptic activity (9) . The CREB-CBP/p300 complex can regulate transcription through HAT activity as well as association with other plasticity-related transcription factors, and genetic studies have demonstrated critical roles for CREB, CBP, and p300 in memory and synaptic plasticity (6, 10, 11) . Conversely, HDACs and other histone-modifying effector enzymes are recruited by co-repressor proteins such as NCoR, SIN3A, MI-2 (NuRD), and CoREST (12) . In neurons, co-repressors have been linked to dynamic and activity-dependent regulation of gene expression and neuron-specific components of co-repressor complexes have also been described (12) , suggesting that these proteins are important in regulating transcription-dependent plasticity. However, few studies have directly addressed the function of the co-repressor proteins in memory and plasticity.
SIN3A is a highly conserved co-repressor protein expressed throughout the brain, in neuronal and in non-neuronal cells. Through its histone-interacting domain (HID), SIN3A recruits a core complex that includes the histone binding proteins RBAP46/48, stabilizing proteins SAP18/20 and SDS3, and the Class I HDAC enzymes HDAC1 and HDAC2 (13, 14) . Four paired-amphipathic helix (PAH) domains mediate binding of the SIN3A-HDAC complex to transcription factors, DNA binding factors, and other co-repressor proteins, facilitating the dynamic recruitment of SIN3A to chromatin (13, 14) . The binding partners of the SIN3A-HDAC complex include several factors linked to neuronal function and cognition, including MEF2, MECP2, NCoR, REST, and
CoREST (12, 14) . Members of the core SIN3A complex, especially HDAC2, have also been shown to regulate memory and plasticity (8, 15) . Recently, mutations in Sin3a have been linked to several cases of autism spectrum disorder and mild intellectual disability in humans, and in vivo knockdown of Sin3a in mouse embryos was shown to lead to dysfunctional cortical neuronal development (16) . These findings suggest that the SIN3A co-repressor complex is in a position to act as a critical regulator of neuronal function and cognition, but this corepressor and its function in the mature nervous system have not been studied.
Pharmacological inhibition of HDAC enzymes facilitates robust enhancements in long-term memory and long-term potentiation (3, 6, 10) . Although a number of acetylation-regulated genes have been identified in these studies, it remains to be defined what downstream mechanisms mediate the enhancement of synaptic plasticity and memory at the level of synaptic function. Similarly, while HDAC2 has been identified as a negative regulator of memory and plasticity in the hippocampus (8) , the mechanisms by which it is recruited to its regulatory targets and ultimately leads to changes in synaptic function has received little attention. Interestingly, blocking the HDAC binding site on the co-repressor NCOR recapitulates the effect of HDAC inhibitor drugs on object memory, highlighting the critical role for co-repressors in bringing epigenetic regulators to gene loci (7) . Here, we address the function of co-repressors in memory storage and synaptic plasticity by conditionally deleting the co-repressor SIN3A in excitatory neurons, demonstrating a role for the SIN3A-HDAC co-repressor complex as a negative regulator of memory and plasticity that exerts its downstream effects through the synaptic scaffold protein Homer1 and the Group I metabotropic glutamate receptors.
RESULTS

Deletion of Sin3a from forebrain excitatory neurons enhances long-term potentiation
To explore the role of SIN3A in synaptic plasticity and memory consolidation, we used the Cre-loxP system to conditionally delete the Sin3a gene in forebrain excitatory neurons ( Figure 1A) . SIN3A protein is reduced by approximately 50% in the hippocampus of Sin3a neuronal hypomorphs (Sin3aNH) relative to control animals (ANOVA: F(1,10)=32.74, p<0.001) (Figure 1B,C) . SIN3A binds HDAC1 and HDAC2, and mediates transcriptional repression through interactions with multiple transcription factors and epigenetic regulatory proteins that have been linked to both positive and negative regulation of gene transcription (Figure 1D) .
HDAC inhibition enhances hippocampal long-term potentiation (LTP), transforming short-term LTP into long-lasting, transcription-dependent LTP (3, 7) . Because SIN3A is a scaffold protein that recruits both HDAC1 and HDAC2 to sites of transcriptional regulation, we hypothesized that reduced neuronal Sin3a would mimic the effects of HDAC inhibition and enhance hippocampal LTP. In hippocampal slices from wild-type control mice, a single tetanus (1 sec, 100 Hz) induces short-lasting LTP that returns to baseline levels within one or two hours after stimulation (6, 17) . In Sin3aNH slices the same weak stimulus produces sustained potentiation that is significantly higher than in controls (controls, n=5; Sin3aNH, n=7; repeated measures ANOVA: genotype, F(1,10)=7.713, p=0.0195; Figure 2A ). This LTP enhancement in Sin3aNH slices is blocked by the transcription inhibitor Actinomycin D ( Supplementary Figure 1) . We also tested basal synaptic properties, paired-pulse facilitation, and synaptic stability at the Schaffer collateral synapses of area CA1. These electrophysiological properties were unchanged in the Sin3aNH mice, indicating that synaptic transmission and the stability and health of slices are not affected by reduced neuronal Sin3a (Figure 2B-E Figure 3A ). However, in Sin3aNH mice, TSA administration did not enhance LTP compared to vehicletreated slices (Sin3aNH+veh, n=4; Sin3aNH+TSA, n=6; Tukey's post-hoc, Sin3aNH+veh vs. Sin3aNH+TSA, p=0.999; Figure 3B ). Further, LTP in Sin3aNH slices was significantly greater than in vehicle-treated control slices but was similar to TSA-treated control slices (repeated measures ANOVA with Tukey's post-hoc test: control+veh vs. Sin3aNH+veh, p=0.012; control+veh vs. Sin3aNH+TSA, p 0.006; control+TSA vs. Sin3aNH+veh, p = 0.894; control+TSA vs. Sin3aNH+TSA, p=0.862; Figure 3C ). The occlusion of the effects of TSA on LTP in Sin3aNH mice and the similarity of LTP enhancement by Sin3a deletion to LTP enhancement by HDAC inhibitor treatment suggest that the changes we observe here in synaptic plasticity are a phenocopy of HDAC inhibition, and that the enhanced LTP phenotypes share a common underlying mechanism.
Reduced Sin3a in forebrain excitatory neurons enhances hippocampal long-term memory
To determine whether reduction of neuronal Sin3a impacts memory consolidation, we tested associative memory in Sin3aNH animals using the contextual fear conditioning paradigm. We tested long-term memory in Sin3aNH and wild type control animals in the foreground contextual fear paradigm, a cognitive task that engages the hippocampus (18, 19) . Sin3aNH animals show enhanced long-term memory compared to controls when tested 24 hours after conditioning (independent samples Kruskal-Wallis, effect of genotype: pre-shock, p<0.13;
24-hr two-tailed unpaired test, p<0.008; Figure 4A ). Consolidation of long-term (24 hour) hippocampal fear memory requires transcriptional activation and translation of new proteins, but short-term (1 hour) memory does not (20, 21) . When we tested a second naïve cohort of animals for short-term contextual fear memory 1 hr after training, we found no differences in the freezing responses of Sin3aNH and control animals to the training context (two-way ANOVA; genotype F(1,44) =0.05, p<0.83; phase F(1,44) =94.1, p <0.001; Figure 4B ). Previous studies of fear learning circuitry suggest that associative fear conditioning to a tone cue is dependent on the amygdala, but not on the hippocampus (22, 23) . When we conditioned a third cohort of Sin3aNH animals in the tone cued fear task, no differences were seen in either baseline freezing pre-CS, or during CS tone presentation (two-way ANOVA: genotype F(1,22) =0.1, p<0.77; phase F(1,22) =21.0, p<0.001); Figure 4C ). This finding together with the enhanced LTP we found in Sin3aNH hippocampal slices (Figure 2) , suggest that the contextual memory enhancements we observed may be specifically due to changes in hippocampal function. We next examined mice for anxiety-related behaviors in the elevated zero maze. Sin3aNH mice show increased time spent in the open sections (two-tailed unpaired t-test, p<0.01) compared to controls, a result suggestive of decreased anxiety in the Sin3aNH animals ( Figure 4D) . The low levels of anxiety-like behaviors in the Sin3aNH mice together with the absence of changes in both 1hr contextual and cued fear responses strongly argue against general fear abnormalities in these animals. Rather, these results indicate that reducing the function of the SIN3A corepressor in excitatory neurons enhances hippocampal long-term memory.
Reduction of neuronal SIN3A changes memory-related gene expression and synaptic signaling.
The effects of SIN3A depletion on transcription-dependent forms of long-term memory and synaptic plasticity support a role for the SIN3A-HDAC complex in regulating the expression of genes involved in neuronal plasticity. Because manipulation of HDACs (whether pharmacologically or genetically) can induce broad changes in gene expression (8, 24, 25) , we sought to use a candidate approach to study genes more specifically associated with the SIN3A repressor complex by focusing on gene loci linked to memory and synaptic plasticity that have been shown by others to be regulated by both HDAC2 and SIN3A (NHGRI ENCODE, http://genome.ucsc.edu/) (8, 26, 27) . To investigate whether expression of these candidate target genes is altered in Sin3aNH mice, we collected hippocampal tissue from Sin3aNH and control animals one hour after contextual fear conditioning and measured mRNA transcript levels by quantitative RT-PCR. Neuronal depletion of SIN3A alters mRNA expression of a subset of HDAC2-regulated synaptic genes, increasing levels of transcripts encoding synaptic scaffold Homer1 and cyclin-dependent kinase Cdk5 (two-tailed unpaired t-test:
Homer1, p<0.001; Cdk5, p<0.02; Gria1, p<0.26; Grin2a, p<0.61; Grin2b, p<0.02; CaMKIIα, p<0.34; Figure 5A ).
Homer1 and Cdk5 are implicated in memory consolidation and both proteins function in a common pathway regulating the localization and function of type I mGluRs, so we further investigated the role of HOMER1 and mGluR signaling in Sin3aNH animals (4, 28) . Two classes of HOMER1 isoforms modulate mGluR signaling at the synapse (29) . Long Homer1 isoforms promote mGluR signaling and recruit mGluRs to the post-synaptic density (30) (31) (32) . Short isoforms of Homer1 act in a dominant negative manner to uncouple mGluRs from the post-synaptic density and from downstream effector molecules (33, 34) . A more detailed examination of Homer1 mRNA expression in Sin3aNH animals revealed an increase in expression across the Homer1 locus, including regions specific to both short isoforms (Homer1a-specific UTR following exon 5, and Ania-3 specific exon A) and long isoforms (exon 10) (two-tailed unpaired t-test: exon 1, p<0.02; Homer1a, p<0.01; Ania-3, p<0.08; exon10, p<0.01; Figure 5B and Supplementary Figure 2A & E). To determine whether these gene-expression changes were induced by learning or were elevated by SIN3A depletion at baseline, we collected hippocampal tissue from Sin3aNH mice and controls under homecage conditions to assay mRNA transcript levels. At baseline, we found no effect of genotype on the expression of Cdk5, Homer1a, or Homer1 exons specific to short and long isoforms (two-tailed unpaired t-test: Cdk5, p=0.2481; Homer1a, p=0.3819; Homer1 exon 1, p=0.8411; Homer1 exon 10, p=0.8636; Figure 5C ). Because Homer1 is a regulatory target of both SIN3A and HDAC2 (8, 26, 27) and because there is evidence that Homer1 transcription is regulated by histone acetylation (4), we used chromatin immunoprecipitation to identify DNA bound by SIN3A in hippocampal tissue, and found that SIN3A binds to the Homer1 promoter just downstream of the transcription start site (Supplementary Figure 2C) . These data provide evidence that SIN3A is a negative regulator of genes involved in synaptic structure and function, including Homer1, and suggest a molecular mechanism by which changes in synaptic Group I mGluR function may underlie behavioral and electrophysiological phenotypes in this model.
The Group I mGluRs (mGluR1 and mGluR5), play important roles in memory and synaptic plasticity (35) (36) (37) (38) , and are upstream of signaling pathways that contribute to plastic processes (Supplementary Figure 7A) .
In CA1 pyramidal neurons, mGluR1 and mGluR5 activation can induce PLC signaling and the release of calcium from intracellular stores, activation of PKC and ERK, activation of local dendritic translation, and potentiation of NMDAR-mediated currents (30, (39) (40) (41) (42) (43) (44) (45) . As regulators of Group I mGluR localization, HOMER1 proteins are a key determinate of cellular processes including synaptic activity, signal transduction, and calcium signaling.
Manipulations that increase levels of Homer1b/c or facilitate activation of mGluR5 have been shown to enhance performance in rodent learning paradigms (46) (47) (48) (49) . To determine whether changes in Homer1 expression by SIN3A lead to alterations in synaptic HOMER1 and mGluR localization, we collected hippocampal tissue from Sin3aNH mutant and wild-type littermates 1hr after contextual fear conditioning and examined Group I mGluR and HOMER1 protein levels at the postsynaptic density. Levels of mGluR5 and long-form Homer1b/c protein, but not PSD95, were significantly higher in the PSD of Sin3aNH mutant mice compared to controls (Figure 5D ).
Interestingly, Homer1b/c mRNA is upregulated in Sin3aNH hippocampal tissue but Grm5 mRNA is not ( Supplementary Figure 2B) , suggesting that increased recruitment of mGluR5 to the PSD may reflect a reorganization of existing receptors secondary to increased HOMER1B/C levels.
To test whether increased levels of synaptic Homer1/mGluR5 alters memory-related signaling cascades downstream of the Group I mGluRs, we assayed levels of ERK1/2 phosphorylation after contextual fear conditioning. ERK phosphorylation is essential for memory formation and synaptic plasticity (19, 50) , is regulated by mGluR1α/5 activity (30), and is necessary for Homer1/mGluR-mediated enhancement of LTP (51) . We measured activation of ERK signaling pathways in hippocampal neurons 1hr after contextual fear conditioning using immunostaining for phosphorylated ERK1/2 in sections from Sin3aNH and control mice ( Figure 5E and Supplementary Figure 3) . Quantification of the immunostained cells revealed a higher number of phospho-ERK1/2 positive cells in area CA1 and the dentate gyrus (DG), but not in area CA3, of Sin3aNH mice compared to control littermates (n=14 for each group; CA1 t-test, p=0.0163; CA3 t-test, p=0.5342; DG, MW u-test, p=0.0162; Fig. 5F ). These results suggest that a reduction in neuronal Sin3a leads to elevated expression of the mGluR scaffold Homer1, and increased activity in mGluR signaling pathways.
Reduction of neuronal Sin3a changes mGluR contributions to long term potentiation
The group I mGluRs play roles in both synaptic potentiation and depression, via agonist-dependent and -independent signaling, and it has been shown that enhancing mGluR5 activation with positive allosteric modulators enhances long-term potentiation (48) . Long-and short-isoform Homer1 interact with an intracellular domain of mGluR1/5 and differentially modulate signaling through downstream effectors (52) . CDK5
phosphorylates the Homer1-binding domain of mGluR5, increasing its affinity for HOMER1 and altering its trafficking and association within the PSD (28) . Changes in Homer1 expression have been linked to changes in synaptic plasticity, and previous studies have shown that increasing expression of long-form HOMER1 protein alters signaling through mGluR1α/mGluR5 in long-lasting forms of synaptic plasticity (49, 53) . Late-phase LTP in hippocampal slices from wild-type mice requires activity of both mGluR1 and mGluR5, but slices overexpressing long isoform Homer1c exhibited a form of LTP that did not require mGluR1 signaling but still depended on mGluR5, through a mechanism that is not entirely clear (53) . To investigate whether the changes we observed in Homer1 expression in Sin3aNH mice similarly affect the contributions of mGluR1α and mGluR5
to synaptic plasticity, we induced L-LTP using spaced 4-train stimulation in the presence of either the mGluR1α antagonist LY367385 or the mGluR5 selective inverse agonist MPEP (35) . When slices from wild-type mice and Sin3aNH mice were stimulated with this protocol in the absence of drug treatment no differences in LTP were observed, indicating L-LTP maintenance is not changed by Sin3a depletion (Supplementary Figure 4) . In control mice, antagonizing either of the type I mGluRs reduced LTP compared to vehicle-treated slices (controls+vehicle, n=6; controls+LY367385, n=5; controls+MPEP, n=5; repeated measures ANOVA: genotype, F(1,28)=17.894, p<0.001; treatment, F(2,28)=20.453, p<0.001; genotype × treatment interaction, F(2,28)=7.924, p=0.0019; Tukey's post-hoc test, controls+vehicle vs. controls+MPEP, p=0.018; controls+vehicle vs. controls+LY367385, p=0.008; Figure 6A ). In slices from Sin3aNH mice, administration of MPEP significantly reduced LTP, while antagonism of mGluR1α with LY367385 did not have a significant effect on potentiation (Sin3aNH+vehicle, n=5; Sin3aNH+LY367385, n=6; Sin3aNH+MPEP, n=7; Tukey's post-hoc test, Sin3aNH+vehicle vs. Sin3aNH+MPEP, p=0.0002; Sin3aNH+vehicle vs. Sin3aNH+LY367385, p=0.999;
Sin3aNH+LY367385 vs. Sin3aNH+MPEP, p=0.0002; Figure 6B ). These results indicate that LTP in Sin3aNH mice is independent of mGluR1α but requires mGluR5, suggesting that increased long Homer1 levels result in very specific changes in the function of the Group I mGluRs at CA1 synapses.
Enhanced mGluR5 signaling in CA1 pyramidal neurons of Sin3aNH mutant mice
Biochemical approaches to probing functional differences in mGluR1 and mGluR5 signaling are difficult to interpret due both to shared mechanisms and the issue of cellular heterogeneity in the region of interest. One way to functionally distinguish between these receptors is by measuring the conversion of the afterhyperpolarization (AHP) that follows a burst of spikes into an afterdepolarization (ADP) that occurs with Group I mGluR activation by DHPG (54, 55) . This AHP-to-ADP conversion requires G-protein signaling, the release of calcium from intracellular stores, PLC activation, and the activation of Cav2.3 R-type voltage-gated calcium channels, and is almost entirely mediated by mGluR5 (54), providing a clear functional differentiation between the Group I mGluRs that could be tested in Sin3aNH mice.
In acute hippocampal slices, we used whole-cell current-clamp recording to measure modulation of the post-burst membrane potential by DHPG in CA1 pyramidal neurons as a readout of Group I mGluR function.
Using C57BL/6J mice, we found that modulation was similar to that previously observed in rat neurons (54) .
Specifically, 15 minutes of perfusion with the mGluR1/5 agonist DHPG converted the medium AHP to an ADP in CA1 neurons, significantly changing the post-burst membrane potential when compared to vehicle-treated cells (t-test, p=0.0298, at 15 minutes; Supplementary Figure 5 ). CA1 pyramidal cells from controls and Sin3aNH mice exhibited a post-burst afterhyperpolarization of similar amplitudes prior to treatment with DHPG (controls, n=7, AHP = -2.201 ± 0.369 mV; Sin3aNH, n=5, AHP = -2.482 ± 0.450; two-tailed unpaired t-test, p=0.638; Figure   7A&B ). In Sin3aNH wild-type controls, CA1 pyramidal neurons exhibited a similar post-burst ADP in response to DHPG administration, while in cells from Sin3aNH mutants, the measured change in the post-burst potential was significantly greater than in controls. Co-application of the mGluR5 inverse agonist MPEP with DHPG almost completely blocked the appearance of the post-burst ADP in both controls and Sin3aNH mutants (controls+DHPG, n=7 cells, ΔV = 2.43 ± 0.66 mV; Sin3aNH+DHPG, n=5 cells, ΔV = 7.49 ± 0.84 mV; controls+DHPG+MPEP, n= 4 cells, ΔV = 0.07 ± 0.44 mV; Sin3aNH+DHPG+MPEP, n=5 cells, ΔV = Figure 7C ). Basic properties of resistance and excitability were also compared between Sin3aNH mutants and controls. Input resistance in CA1 pyramidal neurons from Sin3aNH mice and control littermates was found to be similar (controls, n=23 cells; Sin3aNH, n=24 cells; two-tailed unpaired t-test, p=0.838; Supplementary Figure 6A ). Assaying excitability using step current injections (500 ms duration, +300 pA) revealed that neurons from Sin3aNH animals and control littermates exhibited similar rates of action potential firing (controls, n=10 cells; Sin3aNH, n=9 cells; two-tailed unpaired ttest, p=0.068; Supplementary Figure 6B .)
In summary, these results indicate that in CA1 pyramidal neurons of mice, activation of metabotropic glutamatergic receptors (in particular mGluR5) modulates excitability through the conversion of the post-burst AHP into an ADP. Consistent with an enhancement in mGluR5/Homer1 signaling, Sin3aNH mutant mice exhibited significantly increased ADP amplitude in response to mGluR activation. The enhanced effects of DHPG in Sin3aNH mice, as well as its attenuation by MPEP, supports the hypothesis that upregulated expression of Homer1 and Cdk5 increases signaling through mGluR5. The AHP-ADP conversion modulates neuronal excitability and facilitates postsynaptic spiking (54, 56) , which could in turn support enhanced memory and LTP in the Sin3aNH mice .
DISCUSSION
Inhibition of HDAC activity enhances memory and facilitates neuronal plasticity (1) . However, the precise molecular mechanisms by which these manipulations ultimately affect synaptic and neuronal function are not understood, and the identification of functional effector genes targeted by HDAC inhibition has been challenging.
We targeted the co-repressor SIN3A, a scaffolding protein that coordinates a multi-functional co-repressor complex containing several histone-modifying enzymes including HDAC1 and HDAC2. Mice carrying a conditional neuronal depletion of Sin3a have reduced levels of SIN3A protein in hippocampus. This chronic reduction of SIN3A is accompanied by enhanced hippocampal synaptic plasticity and memory formation, mimicking the effects of acute HDAC inhibitor administration. These enhancements in memory and plasticity are accompanied by increased expression of several neuronal genes regulated by HDAC2 and SIN3A, including Homer1 and Cdk5. Although our data support a role for SIN3A in the regulation of Homer1 transcription ( Figure   5 and Supplementary Figure 2) , further analysis of Homer1 histone acetylation in Sin3aNH hippocampus would clarify the regulatory role of the SIN3A/HDAC complex, and it will still be necessary in the future to use isoformspecific antibodies to determine how Homer1 gene expression changes correlate with HOMER1 protein levels. In fear-conditioned Sin3aNH animals, we observed an increase in PSD protein levels of HOMER1B/C and mGluR5, and increased phosphorylation of ERK, which is a downstream target of group I mGluRs.
Alterations in Homer1 and mGluR functioning have profound effects on synaptic structure, plasticity, and cognition (36, 48, 49, 53) . The upregulation of Homer1, increased synaptic levels of mGluR5 and HOMER1 protein, enhancement of mGluR5-mediated signaling in CA1 pyramidal neurons in Sin3aNH mice, mGluR5dependent AHP-to-ADP conversion, and the observed shift in the requirements for Group I mGluR signaling in Sin3aNH L-LTP indicate that the enhancements we observed in hippocampus-dependent memory and synaptic plasticity are likely attributable in part to changes in synaptic Homer1/mGluR5 signaling, and suggest a model by which these changes could occur. Long isoforms of Homer1 bind to the intracellular C-terminal tails of Group I mGluRs and link them to the postsynaptic density in dendritic spines (31, 32) . Under baseline conditions both mGluR1α and mGluR5 are linked to the postsynaptic density through interactions with long Homer1b/c (Supplementary Figure 7A) . Group I mGluRs are associated with several key signaling pathways associated with memory/plasticity (30, 36, 48) , and under baseline conditions the activation of both mGluR1α and mGluR5 are necessary for long-term potentiation (35) . In Sin3aNH mice, higher levels of long-form Homer1b/c are accompanied by increased localization of mGluR5 to the postsynaptic density ( Figure 5C ) and an enhanced mGluR5-mediated ADP (Figure 7) . There is evidence that mGluR1 and mGluR5 interact as homodimers rather than forming heterodimers (59); a possible explanation is that increased Homer1b/c expression leads to structural changes at the synapse that promote inclusion of mGluR5 and exclusion of mGluR1, leading to a shift in their necessity for LTP. Increased synaptic mGluR5 could reduce the requirement for mGluR1α in activating shared downstream signaling pathways supporting maintenance of LTP, and this may in turn facilitate increased neuronal excitability and postsynaptic spiking (54) . Higher levels of synaptic mGluR5 could also facilitate LTP enhancement via increases in [Ca 2+ ]i (30, 42, 48) , downstream signaling through PKC and ERK (30, 42, 48) , and even NMDA receptor potentiation through Src kinase (42) (Supplementary Figure 7B) . Another potential pathway by which Homer1/mGluR5 activation could enhance hippocampal plasticity and memory is through a mechanism similar to EPSP-spike potentiation; high-frequency stimulation at the CA3-CA1 synapses has been shown to enhance firing rate and improve temporal precision of spiking through the activation of synaptic mGluR5 and subsequent increase in persistent Na + currents in dendrites, even without the emergence of an afterdepolarization (60) .
It is crucial to acknowledge that there is a wide-ranging network of interdependent synaptic signaling molecules upstream, downstream, and parallel to the group I mGluRs that we have not investigated but could contribute significantly to the phenotypes observed in Sin3aNH mice. For example, while ERK is indeed a downstream target of mGluR1α/5 signaling, the Group I mGluRs are can also be a substrate for ERK (61) and ERK is also downstream of numerous synaptic molecules including NMDA receptors and regulators thereof such as Shank, GKAP, and SynGAP (62), all of which may be affected by changes to the postsynaptic density. Indeed, the activation of Src kinase downstream of mGluR5 could potentiate NMDAR signaling and associated signaling networks (42) . While we utilized a candidate-gene driven approach to study the effects of Sin3a depletion as it relates to HDAC inhibition, which lead us to a specific aspect of mGluR5 signaling and interaction with long-form HOMER1, there are other aspects of mGluR/Homer1 interaction we did not explore in Sin3aNH mice but that should be investigated in future work, such as mGluR5-LTD, which is impacted by both HDAC inhibition (63) and Pharmacological inhibition of HDAC enzymes could be an important component of future therapies for not only at improving cognition, but also treating cognitive, neurodevelopmental and neurodegenerative disorders (2, 65) . One of the major obstacles to developing HDAC inhibitor drugs as neural therapeutic agents is a lack of understanding of basic molecular mechanisms driving the synaptic and behavioral effects of these compounds. Here, we show that neuronal depletion of the HDAC-coordinating co-repressor SIN3A alters the expression of HDAC-regulated genes leading to changes in Group I mGluR function and downstream signaling through ERK, and these effects on mGluR5/Homer1 signaling likely mediate the enhancements in memory and plasticity observed in Sin3aNH mice. Indeed, it has recently been demonstrated that increasing mGluR signaling via positive allosteric modulators enhances hippocampal long-term potentiation, long-term depression, and longterm memory consolidation in rodents (48) , while disruption of Group I mGluR function has been implicated in many cognitive and neurological disorders that may also be influenced by histone acetylation (including anxiety disorder, Fragile X syndrome, autism spectrum disorder, Parkinson's disease, and schizophrenia) (41, 66, 67) .
There have been numerous hypotheses that glutamatergic signaling is altered in autism (68) . Group I mGluRs are of special interest in this regard because mGluR gene mutations and altered levels of mGluR5 has been reported not only in individuals with autism (69-71), but also in individuals with Fragile X Syndrome, an autismrelated disorder with high co-incidence of intellectual disability (72) . The therapeutic potential of pharmacological modulators of mGluR5 been tested in patients with Fragile X syndrome in several clinical trials with mixed results (73) (74) (75) , but these trials have largely focused on emotional and behavioral endpoints rather than cognitive functioning. These findings provide evidence linking mGluR signaling at the synapse to epigenetic mechanisms regulating gene expression for the first time, paving the way for novel therapeutics to treat cognitive deficits.
METHODS
Mice
Mutant mice with a forebrain-specific deletion of Sin3a were generated by crossing mice homozygous for a loxP-flanked exon 4 of the Sin3a gene (Sin3a L/L )(76) with mice carrying the CaMKIIα-Cre transgene (L7ag#13) were separated by gel electrophoresis, purified, and sequenced. In Sin3aNH, a full length Sin3a product and a single recombined Sin3a product were identified (HS, unpublished observations). All genotypes produced from this mating were examined in fear conditioning. No differences were observed among genotypes with the exception of Sin3aNH mice, so all other genotypes were grouped for controls in the presented data.
Experimenters were blind to the genotypes of the mice during collection of behavioral and electrophysiological data. CaMKIIα-Cre line L7ag#13 expresses Cre recombinase throughout the forebrain including the hippocampus, cortex, and amygdala with the majority of recombination occurring postnatally (77) . These Sin3aNH mice were produced after more than 6 generations of backcrossing of the loxP-flanked Sin3a allele and more than 9 generations of backcrossing the CaMKIIα-Cre transgene into C57BL/6J. Both male and female wild-type and Sin3aNH mice were used for these biochemical, behavioral, and electrophysiological experiments.
Because of the difficulties associated with the breeding of this strain of mice, these studies were not powered to detect sex differences, but sexes were balanced among groups to eliminate sex-driven biases in our conclusions. 
Immunoblots
Hippocampal lysation and immunoblotting were conducted as previously described (78) . Mice were cervically dislocated, and hippocampi were quickly dissected and flash frozen on dry ice. Hippocampi were homogenized at 4° C in 500 µL of cell lysis solution (10 mM HEPES pH 7.9, 1 mM EDTA, 1.5 mM MgCl2, 10 mM KCl, 1% protease inhibitor cocktail (Sigma), 1 mM DTT), and nuclei were pelleted by 20 min centrifugation at 1000 x g at 4° C. Nuclear pellets were resuspended in 100 µL of nuclear lysis buffer (20 mM HEPES pH 7.9, 0.2 mM EDTA, 1.5 mM MgCl2, 400 mM KCl, 25% glycerol, 1% protease inhibitor cocktail (Sigma), 1mM DTT).
After 30 min incubation on ice, samples were centrifuged at 4° C for 20 min at 1000 x g. Protein concentrations of the supernatants were quantified by the Bradford method (Biorad). Nuclear protein samples were prepared using 20 µg fractionated protein combined with NuPage LDS sample buffer and 2-mercaptoethanol (Invitrogen) and incubated for 5 min at 100° C. Proteins were separated on a 3-8% Bis-Tris gel (Novex, Life Technologies) for 1 hr and transferred to a PVDF membrane for immunoblotting. Membrane was blocked with 5% milk/PBST for 2 hrs at room temperature (RT), and incubated with anti-SIN3A (Sigma, S6695) 1:500 in 2% milk/PBST at 4° C overnight. Membrane was washed three times in PBST for 10 min and incubated with anti-rabbit HRP conjugated secondary antibody (sc-2004, Santa Cruz Biotechnology) 1:1000 in 2% milk/PBST for 2 hr at RT.
After three 10 min washes in PBST, the membrane was incubated for 1 min in ECL Western Blotting Detection
Reagent (GE Healthcare) and developed on film. For detection of β tubulin control band, antibody was removed from the blot using Restore Western Blot Stripping Buffer (Thermo Scientific) according to the manufacturer's instructions. The membrane was re-blocked and re-probed with antiβ tubulin antibody (Sigma, T4026) using the same blotting protocol.
Gene expression
Hippocampal RNA was purified and cDNA was prepared as previously described (78) . Following contextual conditioning, hippocampal dissections were performed on ice, and tissue stored in RNA Later (Qiagen) at -80° C until RNA extraction. RNA was isolated by Trizol extraction and purified using an RNeasy kit (Qiagen) according to the manufacturer's instructions. RNA concentration was measured using a NanoDrop spectrophotometer (ThermoFisher Scientific). Template cDNA was synthesized from 1 μg total RNA using the RETROscript kit with oligo(dT) primers (Ambion). Reactions were conducted at 44° C for 1 hr, heat inactivated at 100° C for 10 min, and the final products were diluted in water to a final concentration of 2 ng/μL. Real time qPCR was performed on the Viia7 Real Time PCR platform (Applied Biosystems) in 5 µL reactions consisting of 4.5 ng cDNA, 2.5 μL Fast SYBR Green master mix (Applied Biosystems), and 250nM forward and reverse primers. Samples that did not amplify were excluded from analysis. Values were normalized to three housekeeper genes (Gapdh, ActB, ActG), and relative quantification was calculated using a ΔΔCt method as described previously (6) . Relative gene expression is reported as the fold difference in mean values for distinct biological replicates.
Behavior
Fear conditioning was conducted as previously described (78) . For contextual conditioning, naïve 2-to 6-month old male and female Sin3a NH (CaMKIIα-Cre; Sin3a L/L ) and control (CaMKIIα-Cre; Sin3a L/+ , and Sin3a L/L ) mice were placed in a novel training chamber for 180 seconds and a single 2 second, 0.75 mA foot shock was administered after 148 s. Contextual fear testing was conducted 1 hour or 24 hours after training, by re-exposing the animals to the trained context for 5 minutes. Cued fear conditioning was conducted using a similar training procedure as contextual fear, with the addition of a 30 second tone presentation starting at 120 seconds. Cued fear testing was conducted in a novel conditioning chamber with altered floor covering, odor, and dimensions. Mice were exposed to the novel context for 3 minutes, followed immediately by 3 minutes of tone presentation. Freezing behavior during contextual and cued testing was scored by computer using FreezeScan software (Clever Systems). Freezing levels for all groups was examined for normality using Shapiro-Wilk test.
Normally distributed data sets were compared using two-way ANOVA, with significance levels of p < 0.05. Nonparametric data were compared using independent samples Kruskal-Wallis test, with p value significance level of 0.05. For all conditioning experiments, animals with responses two standard deviations above or below the group mean were excluded from the analysis as outliers. Mice were tested in the elevated zero maze with a single 5 minute exposure in which the animals were allowed to freely explore the maze. Time spent in open and closed quadrants of the maze were scored manually by a trained observer blind to the genotypes of the animals.
A two-tailed independent samples t-test was used to compare genotypes for open and closed areas. For all behavioral tasks, testing order was designed so that mice of different sexes were not in the testing room at the same time. Testing chambers were thoroughly cleaned between each session to minimize odor cues.
Subcellular fractionation and semi quantitative western blotting
Subcellular fractionation was conducted for the hippocampus of Sin3a NH and control mice following the protocol as previously described (79, 80) . Briefly 20-30 mg hippocampal tissue from male mice were homogenized in 25 mM Tris-HCl, pH 7.4 containing 320 mM Sucrose, 0.5 mM EDTA, 0.5 mM EGTA in presence of protease and phosphatase inhibitor cocktails (Sigma, USA). The homogenates were centrifuged at 800xg to and the supernatant was centrifuged at 19,200xg . The pellets containing crude synaptosomal membranes were suspended in 25 mM Tris-HCL, pH 7.4, containing 0.5mM EDTA, 0.5mM EGTA and protease and phosphatase inhibitors. Two thirds of the synaptosomal membranes were precipitated in 1% Triton-X buffer for 1.5 hours at 4 degrees C to obtain fractions enriched for the postsynaptic density (PSD). Synaptosomal membrane (P2) and post synaptic density fractions (PSD) were size fractionated in 7.5% Tris Glycine (Biorad, USA) gels and examined by western blotting with the antibodies for Homer 1 (anti-mouse, Santa Cruz Biotechnology, USA, sc-136358), mGlur5 (anti-goat, Santa Cruz Biotechnology, USA, sc-47147), PSD-95 (anti-mouse, Neuro Mab, USA, 75-028), and β-actin (anti-mouse, Sigma, USA, A2228). The quantified band intensities were analyzed and plotted using the Graph Pad Prism software; all data were expressed as mean ± SEM (standard error of the mean), Students' test, unpaired and two-tailed, was used for between group comparisons.
Immunohistochemistry
Transcardial perfusions and immunohistochemical staining were conducted as previously described (17) .
Sections were incubated with rabbit anti-phopsho-ERK1/2 (Cell Signaling, AB9101). Phosphatase inhibitors were included in the fixative and all buffers (17) . Cell counts were conducted as described (17) by a trained observer blind to grouping. Groups were compared using a two-tailed independent samples t-test or Mann-Whitney U-test as appropriate.
Electrophysiology
Field Recordings: To assess the effects of conditional Sin3a mutation on LTP, 2-to 6-month old male and female mice were killed by cervical dislocation and their hippocampi quickly dissected out into ice-cold oxygenated artificial CSF (aCSF; 124 mM NaCl, 4.4 mM KCl, 1.3 mM MgSO4•7H2O, 1 mM NaH2PO4•H2O, 26.2 mM NaHCO3, 2.5 mM CaCl2•2H2O, 10 mM D-glucose). Transverse hippocampal slices were cut 400 µm thick using a tissue chopper (Stoelting Co., Wood Dale, IL), placed in an interface chamber, and perfused with oxygenated aCSF at 28°C at a flow rate of 1 mL/min. Slices were allowed to recover for at least 2 hours before beginning electrophysiological recordings. Single-pathway recordings were made using a single bipolar stimulating electrode made from nichrome wire (A-M Systems, Sequim, WA) placed in the stratum radiatum and used to elicit action potentials in the axons of CA3 pyramidal neurons. Field potentials (fEPSPs) were recorded using an aCSF-filled glass microelectrode (A-M Systems) with a resistance between 1 and 5 MΩ placed in the stratum radiatum region of CA1. Data collection was handled by Clampex software (Molecular Devices, Palo Alto, CA) and was analyzed using Clampfit software (Molecular Devices). The peak fEPSP amplitude induced by the stimulating electrode was required to be at least 5 mV, and stimulus intensity during the recording was set to produce a response of 40% of the maximum fEPSP amplitude. Test stimulation occurred once every minute. Baseline responses were recorded for 20 minutes before LTP induction or drug application. To examine early-phase LTP (E-LTP) one 1-second, 100 Hz train of stimuli was applied through the stimulating electrode.
To examine late-phase LTP (L-LTP) four 1-second, 100 Hz trains of stimuli were delivered 5 min apart.
Recordings continued for at least 160 min after LTP induction. The initial slope of the recorded fEPSPs were normalized to the average of the 20 baseline traces and expressed as percentages of this baseline value.
Single-cell recordings:
Slices were prepared as previously described (54, 55) . Briefly, near-horizontal slices (∼300 μm thick) were prepared from postnatal day 21-30 brains, using a vibrating tissue slicer (Microm HM 650 V Vibration microtome, Thermo Scientific Inc., Waltham, MA). Animals were anaesthetized with isofluorane, decapitated, and the brain was rapidly removed and placed in ice-cold sucrose slicing solution containing (in mM): 215 Sucrose, 2.5 KCl, 1.25 NaH2PO4, 2.8 NaHCO3, 7 Dextrose, 3 Na-Pyruvate, 1 Na-Ascorbate, 0.5 CaCl2, 7 MgCl2 (pH 7.4, oxygenated with 95% CO2 and 5% O2). After sectioning, slices were transferred to a warmed (35°C) incubation chamber for 30 minutes with bubbled artificial cerebrospinal fluid (aCSF) consisting of (in mM):
125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 25 NaHCO3, 25 Dextrose, 2 CaCl2, 1 MgCl2, 3 Na-Pyruvate, 1 Na-Ascorbate.
Slices were then maintained in bubbled aCSF at room temperature until transferred to the recording chamber.
Whole-cell current-clamp recordings were conducted as previously described (54, 55) . Briefly, during recordings, slices were continuously perfused with bubbled aCSF and maintained at a temperature of 34°C.
Somatic whole-cell current-clamp recordings were made using patch-clamp electrodes pulled from borosilicate glass and filled with intracellular solution containing (in mM): 115 K-gluconate, 20 KCl, 10 Na2-phosphocreatine, 15-25 MΩ; bridge balance and capacitance compensation were used to minimize the resultant errors.
Recordings were made using a Dagan BVC-700 amplifier (Dagan Corporation, Minneapolis, MN). Data were low-pass filtered at 3 or 5 kHz, and digitized at 50 kHz via an ITC18 digital-analog converter (HEKA Instruments Inc., Bellmore, NY) under control of IGOR Pro (Wavemetrics, Lake Oswego, OR) using the DataPro software package from the lab of Nelson Spruston (www.janelia.org/lab/spruston-lab/resources/software). Patched cells were maintained at a potential of -65 mV, with a holding current when needed no larger than ±100 pA. A 100 Hz burst of 5 somatic spikes was induced by current injection (+2000 pA, 2 ns, × 5), with an ISI of 20 seconds.
Baseline responses were recorded for 3 minutes before beginning drug or vehicle perfusion. Recordings lasted for 30 minutes after the baseline recording period. Drug perfusion lasted for 15 minutes before washout.
Electrophysiological data was analyzed using custom scripts written for use with IGOR Pro software and the DataPro package. Statistical analyses were performed using STATISTICA 11 software and Prism 6 software (6) . For LTP experiments, drug application was initiated 20 minutes prior to induction and lasted for 10 minutes (mGluR antagonists) or for the duration of the recording (TSA and Actinomycin-D).
Statistical analyses: Initial slope of the fEPSP was used to quantify synaptic potentiation, normalized to the averaged value of the 20-minute baseline. Only one slice per animal was included in any treatment condition.
Within each LTP experiment, recordings were made from multiple slices from each mouse whenever possible to reduce the number of animals used. The order of treatment was determined randomly on each day of recording.
Sample sizes were not predetermined using statistical methods, but the sample sizes in our experiments are similar to those reported in similar previously published research from our lab and others (6, 17) . To evaluate potential differences in paired-pulse facilitation a repeated measures ANOVA was used with genotype and interstimulus interval as factors and the facilitation ratio as the dependent variable. For evaluation of input-output characteristics, a two-tailed independent samples t-test was performed comparing the average linear regression slopes for control mice and Sin3aNH mice. Potential differences in the maximum fEPSP slope were evaluated using a two-tailed independent samples t-test. Between-group differences in LTP maintenance were determined using a repeated measures ANOVA on the final 20 minutes of the recordings, followed by Tukey's post-hoc test when appropriate (6) . Normality and variance of LTP data were checked to determine suitability for analysis by ANOVA. Normality of the data was evaluated by Shapiro-Wilk tests and examination of normal probability plots of the residuals. Variance was evaluated by examination of residual plots of observed versus fitted values. All statistical analyses were performed using STATISTICA software (StatSoft Inc.; Tulsa, OK).
Statistics
Experiment-specific statistical methodology is included in greater detail in the appropriate Methods section.
Briefly, all data for tested for normality using Shapiro-Wilk tests before performing statistical comparisons.
Between-group comparisons were made using unpaired two-tailed t-tests if normally distributed, or nonparametric Mann-Whitney U-tests if non-normally distributed. When comparisons were made between multiple groups, two-way ANOVA was used for normally distributed data followed by Holm-Sidak's multiple comparisons test, while an independent samples Kruskal-Wallis test was used for non-parametric data. For comparisons between two groups over time a repeated-measures ANOVA was used, followed by Tukey's post-hoc test.
Significance for all statistical tests was set at p < 0.05. In all figures, significance is indicated as: *p < 0.05; **p < 0.01; ***p < 0.001. All data are presented as individual data points with mean ± SEM. No significant difference was observed between control+TSA, Sin3aNH+veh, and Sin3a+TSA groups; these groups all displayed higher potentiation than control+veh slices (repeated measures ANOVA, Tukey's post-hoc, control+veh vs. Sin3aNH+veh, *p=0.012; control+veh vs. Sin3aNH+TSA, **p=0.006; control+TSA vs.
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Sin3aNH+veh, p=0.894; control+TSA vs. Sin3aNH+TSA, p=0.862). All data are presented as mean ± SEM. Sin3aNH; unpaired two-tailed t-test, Exon 1 t(1,11)=-2.877, *p<0.02; Homer1a, t(1,11)=-3.313, **p<0.01; Ania-3, t(1,11)=-2.146, p<0.08; Exon 10, t(1,11)=-3.251, **p<0.01). (C) Expression of Cdk5 and Homer1 is not affected at baseline by Sin3a depletion (n=6 control, n=6 Sin3aNH; unpaired two-tailed t-tests; Cdk5 t(1,10)=1.227, p=0.2481;
Homer1a t(1,10)=0.9146, p=0.3819; Homer1 Exon 1 t(1,10)=0.2058, p=0.8411; Homer1 Exon 10, t(1,10)=0.1763, controls + LY367385, n=5, avg. fEPSP slope = 121.82 ± 20.67%; controls + MPEP, n=5, avg. fEPSP slope = 120.96 ± 6.56%; repeated measures ANOVA: genotype, F(1,28)=17.894, p=0.00023; treatment, F(2,28)=20.453, p=0.000003; genotype × treatment interaction, F(2,28)=7.924, p=0.0019; Tukey's post-hoc test, controls+vehicle vs. controls+MPEP, *p=0.018; controls+vehicle vs. controls+LY367385, **p=0.008). (B) In Sin3aNH slices, application of an mGluR5 antagonist impairs spaced 4-train LTP, while antagonizing mGluR1α has no effect (Sin3aNH+veh, n=5, avg. fEPSP slope = 192.29 ± 17.4%; Sin3aNH+LY367385, n=6, avg. fEPSP slope = 213.12 ± 7.62%; Sin3aNH+MPEP, n=7, avg. fEPSP slope = 116.06 ± 10.94%; Tukey's post-hoc test, Sin3aNH+ vehicle vs. Sin3aNH+MPEP, ***p=0.0002; Sin3aNH+vehicle vs. Sin3aNH+LY367385, p=0.999; Sin3aNH+LY367385 vs.
Sin3aNH+MPEP, ***p=0.0002). All data are presented as mean ± SEM. 
